DexCom is a medical device company that focuses on helping diabetes patients achieve better health outcomes. The company currently generates most of its revenue from its G6 continuous glucose monitoring (CGM) system, which helps those with diabetes keep track of their blood glucose levels.
In the first nine months of 2021, the company’s revenue increased 28.9% to $1.8 billion over the prior-year period while net income jumped 25.8% to $174.1 million.
You're not a member! Trial today
